NCT05303324View on ClinicalTrials.gov

Study of Oral ALXN1840 at 2 Dose Strengths in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 4, 2019

Primary Completion Date

October 9, 2019

Study Completion Date

October 9, 2019

Conditions
Healthy
Interventions
DRUG

ALXN1840

Participants received ALXN1840 at Hour 0 on Day 1 of the dosing period.

Trial Locations (1)

SE11YR

Clinical Trial Site, London

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY